These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4939474)

  • 41. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
    Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
    Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [An experimental analysis of the origin of antibody producing cells in the spleen of an intact recipient following transplantation of cells from an immunized donor].
    Fontalin LN; Pevnitskiĭ LA; Kraskina NA
    Biull Eksp Biol Med; 1967 Nov; 63(11):108-13. PubMed ID: 5634195
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanisms of immunosuppression by heterologous anti-lymphocyte serum (ALS) and plasma (ALP).
    Jeejeebhoy HF; Rabbat AG; Vela-Martinez JM
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):132-7. PubMed ID: 4913082
    [No Abstract]   [Full Text] [Related]  

  • 45. Characterization of an immunosuppressive factor present in mouse serum.
    Veit B; Michael JG
    J Immunol; 1973 Aug; 111(2):341-51. PubMed ID: 4736937
    [No Abstract]   [Full Text] [Related]  

  • 46. Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells.
    Gorczynski RM; Miller RG; Phillips RA
    J Immunol; 1972 Feb; 108(2):547-51. PubMed ID: 5065602
    [No Abstract]   [Full Text] [Related]  

  • 47. Murine skin allograft histocompatibility combinations susceptible to induction of tolerance by intraportal inoculation of allogeneic spleen cells.
    Yabusaki N; Komatsu H; Tasaka K; Ueno A
    Transplant Proc; 1993 Apr; 25(2):2124-5. PubMed ID: 8470290
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of some alkylating agents and whole-body ionizing radiation on the formation and realization of immunologic memory].
    Kazarian KA; Fontalin LN; Pevnitskiĭ LA; Solov'ev VV
    Biull Eksp Biol Med; 1971 Nov; 72(11):58-61. PubMed ID: 5002198
    [No Abstract]   [Full Text] [Related]  

  • 49. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of migration activity of sensitized mouse spleen cells in the presence of trans-plantation antigens in vitro.
    Hasková V; Svejcar J; Pekárek J; Johanovský J; Hilgert I
    Folia Biol (Praha); 1967; 13(4):293-8. PubMed ID: 4863403
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of immunological response of isolated Peyer's patches, whole spleen and spleen lymphatic nodules from mice immunized with sheep red blood cells.
    Kamiński M; Pieńkowski M; Abramczuk J
    Folia Biol (Praha); 1972; 18(3):198-202. PubMed ID: 5064718
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunological considerations of bone marrow transplantation.
    Uphoff DE
    Transplant Proc; 1969 Mar; 1(1):39-43. PubMed ID: 4944248
    [No Abstract]   [Full Text] [Related]  

  • 54. [Capability of antibody-producing cells, cultivated in vitro, of interacting with a specific antigen].
    Iarvelov BN; Pinegin BV; Uteshev BS
    Biull Eksp Biol Med; 1971 Oct; 72(10):68-9. PubMed ID: 4942311
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunosuppression by the bisdioxopiperazines ICRF 154 and 159.
    Duke DI; Field EO; Finch M; Hellmann K; Tucker AS; Tucker DF
    Biomedicine; 1973 May; 18(3):199-205. PubMed ID: 4147539
    [No Abstract]   [Full Text] [Related]  

  • 56. Antitumor agents on the production of primary and secondary spleen hemolysin plaque-forming cells.
    Uyeki EM; Long J
    J Pharmacol Exp Ther; 1967 Nov; 158(2):365-71. PubMed ID: 6065156
    [No Abstract]   [Full Text] [Related]  

  • 57. [The immunologic reactivity of mice with transplantable Harding-Passey melanoma].
    Kovalev IE; Grigor'ian-Kovaleva VL; Rubtsova ED; Burkin AA; Shaĭdrov VV
    Vopr Onkol; 1971; 17(4):55-8. PubMed ID: 4935523
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results.
    Terenzi A; Aristei C; Aversa F; Perruccio K; Chionne F; Raymondi C; Latini P; Martelli MF
    Transplant Proc; 1996 Dec; 28(6):3101. PubMed ID: 8962201
    [No Abstract]   [Full Text] [Related]  

  • 59. Allogeneic suppression: inhibition of antibody plaque forming cells in vitro by non-sensitized lymphoid cells.
    Friedman H
    Transplant Proc; 1969 Mar; 1(1):574-6. PubMed ID: 4944273
    [No Abstract]   [Full Text] [Related]  

  • 60. The localization of haemolytic antibody in sections of lymphoid organs: an improved method.
    Berenbaum MC; Stringer IM
    Immunology; 1970 Jan; 18(1):85-90. PubMed ID: 5411499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.